Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | EHMT2 | Q96KQ7 | 6/20 | 0.45 |
| ▸ | WHR1 | P49842 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14715472 | 0.92 | ADRA1A (0.44) | ADRA2AADRA2BADRA2CADRA1DADRA1A | |
| SCHEMBL14715376 | 0.89 | WHR1 (0.46) | ADRA1AADRA1BEHMT2WHR1HDAC1 | |
| SCHEMBL14715357 | 0.88 | EHMT2 (0.45) | EHMT2WHR1HDAC1EHMT1HDAC6 | |
| SCHEMBL2171942 | 0.88 | ADRA2A (0.48) | ADRA2AADRA2BADRA2CADRA1DADRA1A | |
| SCHEMBL14715407 | 0.88 | EHMT2 (0.48) | ADRA1DADRA1AADRA1BEHMT2WHR1 | |
| SCHEMBL14715363 | 0.84 | EHMT2 (0.44) | ADRA2AADRA2BADRA2CADRA1DADRA1A | |
| SCHEMBL14715427 | 0.84 | PDGFRB (0.43) | ADRA1AADRA1BWHR1 | |
| SCHEMBL14715298 | 0.84 | WHR1 (0.44) | ADRA1AADRA1BEHMT2WHR1HDAC1 | |
| SCHEMBL14715442 | 0.84 | WHR1 (0.44) | ADRA1AADRA1BEHMT2WHR1HDAC1 | |
| SCHEMBL14715393 | 0.84 | EHMT2 (0.45) | ADRA1AADRA1BEHMT2WHR1EHMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346848-B1 | QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2013-02-27 | — | — | EP | claimed |